Development and Characterization of Thiolated Cyclodextrin-Based Nanoparticles for Topical Delivery of Minoxidil.

cyclodextrin hair adhesion hair keratin minoxidil thiomers

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
01 Dec 2023
Historique:
received: 09 10 2023
revised: 23 11 2023
accepted: 26 11 2023
medline: 23 12 2023
pubmed: 23 12 2023
entrez: 23 12 2023
Statut: epublish

Résumé

The aim of this research was to prepare adhesive nanoparticles for the topical application of Minoxidil (MXD). Thiolated β-CDs were prepared via conjugation of cysteamine with oxidized CDs. MXD was encapsulated within thiolated and unmodified β-CDs. Ionic gelation method was used to prepare nanoparticles (Thio-NP and blank NP) of CDs with chitosan. Nanoparticles were analyzed for size and zetapotential. Inclusion complexes were characterized via FTIR. Drug dissolution studies were carried out. An in vitro adhesion study over human hair was performed. An in vivo skin irritation study was performed. Ex vivo drug uptake was evaluated by using a Franz diffusion cell. Thiolated β-CDs presented 1804.68 ± 25 μmol/g thiol groups and 902.34 ± 25 μmol/g disulfide bonds. Nanoparticles displayed particle sizes within a range of 231 ± 07 nm to 354 ± 13 nm. The zeta potential was in the range of -8.1 ± 02 mV, +16.0 ± 05 mV. FTIR analyses confirmed no interaction between the excipients and drug. Delayed drug release was observed from Thio-NP. Thio-NP retained over hair surfaces for a significantly longer time. Similarly, drug retention was significantly improved. Thio-NP displayed no irritation over rabbit skin. Owing to the above results, nanoparticles developed with MXD-loaded thiolated β-CDs might be a potential drug delivery system for topical scalp diseases.

Identifiants

pubmed: 38140057
pii: pharmaceutics15122716
doi: 10.3390/pharmaceutics15122716
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Ammara Akhtar (A)

Institute of Pharmaceutical Sciences, UVAS, Lahore 54000, Pakistan.

Muhammad Khurram Waqas (MK)

Institute of Pharmaceutical Sciences, UVAS, Lahore 54000, Pakistan.

Arshad Mahmood (A)

College of Pharmacy, Al Ain University, Abu Dhabi Campus, Abu Dhabi P.O. Box 112612, United Arab Emirates.
AAU Health and Biomedical Research Center (HBRC), Al Ain University, Abu Dhabi P.O. Box 112612, United Arab Emirates.

Saira Tanvir (S)

Riphah Institute of Pharmaceutical Sciences, Ripha International University, Islamabad 44000, Pakistan.

Talib Hussain (T)

Institute of Pharmaceutical Sciences, UVAS, Lahore 54000, Pakistan.

Mohsin Kazi (M)

Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.

Muhammad Ijaz (M)

School of Veterinary Medicine, University College Dublin, Belfield, D04 C1P1 Dublin, Ireland.
Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Defense Road, 1.5 Km Off Raiwind Road, Lahore 54000, Pakistan.

Mulazim Hussain Asim (MH)

College of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.

Classifications MeSH